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mates of childhood stroke burden are important for plan-
ning research and the resulting evidence-based strategies 
for stroke prevention and management.  Objectives: To esti-
mate the prevalence, mortality and disability-adjusted life 
years (DALYs) for ischemic stroke (IS), hemorrhagic stroke 
(HS) and all stroke types combined globally from 1990 to 
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 Abstract 
 Background: There is increasing recognition of stroke as an 
important contributor to childhood morbidity and mortality. 
Current estimates of global childhood stroke burden and its 
temporal trends are sparse. Accurate and up-to-date esti-
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2013.  Methodology: Stroke prevalence, mortality and DALYs 
were estimated using the Global Burden of Disease 2013 
methods. All available data on stroke-related incidence, 
prevalence, excess mortality and deaths were collected. Sta-
tistical models and country-level covariates were employed 
to produce comprehensive and consistent estimates of 
prevalence and mortality. Stroke-specific disability weights 
were used to estimate years lived with disability and DALYs. 
Means and 95% uncertainty intervals (UIs) were calculated 
for prevalence, mortality and DALYs. The median of the per-
cent change and 95% UI were determined for the period 
from 1990 to 2013.  Results: In 2013, there were 97,792 (95% 
UI 90,564–106,016) prevalent cases of childhood IS and 
67,621 (95% UI 62,899–72,214) prevalent cases of childhood 
HS, reflecting an increase of approximately 35% in the abso-
lute numbers of prevalent childhood strokes since 1990. 
There were 33,069 (95% UI 28,627–38,998) deaths and 
2,615,118 (95% UI 2,265,801–3,090,822) DALYs due to child-
hood stroke in 2013 globally, reflecting an approximately 
200% decrease in the absolute numbers of death and DALYs 
in childhood stroke since 1990. Between 1990 and 2013, 
there were significant increases in the global prevalence 
rates of childhood IS, as well as significant decreases in the 
global death rate and DALYs rate of all strokes in those of age 
0–19 years. While prevalence rates for childhood IS and HS 
decreased significantly in developed countries, a decline 
was seen only in HS, with no change in prevalence rates of 
IS, in developing countries. The childhood stroke DALY rates 
in 2013 were 13.3 (95% UI 10.6–17.1) for IS and 92.7 (95% UI 
80.5–109.7) for HS per 100,000. While the prevalence of 
childhood IS compared to childhood HS was similar globally, 
the death rate and DALY rate of HS was 6- to 7-fold higher 
than that of IS. In 2013, the prevalence rate of both child-
hood IS and HS was significantly higher in developed coun-
tries than in developing countries. Conversely, both death 
and DALY rates for all stroke types were significantly lower 
in developed countries than in developing countries in 2013. 
Men showed a trend toward higher childhood stroke death 
rates (1.5 (1.3–1.8) per 100,000) than women (1.1 (0.9–1.5) 
per 100,000) and higher childhood stroke DALY rates (120.1 
(100.8–143.4) per 100,000) than women (90.9 (74.6–122.4) 
per 100,000) globally in 2013.  Conclusions: Globally, be-
tween 1990 and 2013, there was a significant increase in the 
absolute number of prevalent childhood strokes, while ab-
solute numbers and rates of both deaths and DALYs de-
clined significantly. The gap in childhood stroke burden be-
tween developed and developing countries is closing; how-
ever, in 2013, childhood stroke burden in terms of absolute 
numbers of prevalent strokes, deaths and DALYs remained 
much higher in developing countries. There is an urgent 
need to address these disparities with both global and coun-
try-level initiatives targeting prevention as well as improved 
access to acute and chronic stroke care. 
 © 2015 S. Karger AG, Basel 
 Introduction 
 Stroke is a significant cause of acquired brain injury 
and morbidity in children  [1–3] . Advances in non-inva-
sive neuroimaging have improved the detection of child-
hood strokes, overcoming challenges due to frequent 
stroke mimics in children and a lack of clinical suspicion 
of stroke at younger ages. The unique mechanisms un-
derlying stroke pathophysiology in childhood remain 
poorly understood  [4, 5] . However, acknowledged risk 
factors for childhood stroke include congenital heart dis-
ease, sickle cell disease, infections, arteriopathy  [6] and 
a number of prothrombotic conditions  [7–9] . Current 
estimates of incidence vary from 1.3 to 13 per 100,000, 
and in neonates, the incidence approximates 1 in 2,500–
5,000 live births  [2, 10–24] . Child mortality rates have 
been reported at 3.1, 0.4 and 0.2 per 100,000 for children 
under 1, 1–4 and 5–14 years, respectively  [25] . Varia-
tions in rates across studies reflect variations in study 
designs and methodologies including diagnostic criteria 
(imaging ascertainment or not), ascertainment by Inter-
national Classification of Disease (ICD) code alone or 
with validated diagnoses, hospital-based versus popula-
tion-based settings, different age ranges captured, the in-
clusion of ischemic stroke (IS) and/or hemorrhagic 
stroke (HS), the geographical region or ethnic break-
down of the population studied and the magnitude of 
population studied  [2] . Improved diagnosis and post-
stroke care may have led to an apparent increase in 
stroke prevalence and decline of case fatalities in chil-
dren. While there have been suggestions that stroke in-
cidence may be increasing over time, robust support for 
temporal changes is lacking.
 Reliable epidemiological data of long-term trends, as 
well as the current burden of childhood stroke, are re-
quired in order to better understand the nature and im-
pact of its burden globally and potential regional varia-
tions, as well as to inform population-level care and pre-
vention strategies. This paper aims to describe global, 
region- and country-specific estimates of the prevalence, 
mortality, disability-adjusted life years (DALYs) and 
trends for IS and HS in children aged 0–19 years between 
1990 and 2013 produced as part of the Global Burden of 
Disease (GBD) study 2013.
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 Methods 
 Stroke modeling and methods used to estimate all-cause mor-
tality, cause-specific mortality, disability and disease prevalence 
are described elsewhere  [26, 27] . In brief, all available data on mor-
tality were corrected for non-specific codes and used to estimate 
mortality rates for GBD causes of death, including IS and HS. An 
ensemble modeling method was used to estimate death rates by 
age, sex, year and country  [28] . Disease prevalence was estimated 
using DisMod-MR disease modeling software  [29] and Bayesian 
geospatial models. We selected estimates of stroke incidence, prev-
alence and case fatality from a systematic review of the scientific 
literature, population surveys and stroke registries as well as GBD 
mortality estimates. Criteria for selection were replicated from the 
GBD adult stroke strategy  [26] .
 Disability due to acute stroke was considered to last for 28–30 
days, while chronic stroke lasted from 30 days until death. Stroke-
specific disability weights were derived as part of the GBD study. 
DALYs were calculated as the sum of years of life lost prematurely 
due to stroke, based on maximum observed global longevity and 
years lived with disability. Countries were defined as developing or 
developed using GBD methods. For this analysis of childhood 
stroke, results were aggregated for the age group of 0–19 years, in-
cluding separate estimates of death and DALY rates produced for 
neonates of age 0–6, 7–27 and 28–264 days.
 Results 
 Prevalence 
 GBD 2013 . Globally, in 2013, there were 97,792 (95% 
uncertainty intervals (UIs) 89,651–102,512) prevalent 
cases of HS and 95,847 (95% UI 90,564–106,016) preva-
lent cases of IS among those aged 0–19 years. Men had 
higher prevalence of both IS and HS than women.
 Developing vs. Developed Countries . In 2013, the prev-
alence rate of IS was 4- to 5-fold higher in developing 
countries, compared to that in developed countries, while 
the prevalence rate for HS was approximately 2-fold high-
er in developing countries ( table  2 ). Men aged 15–19 
years had the highest prevalence rates for both IS and HS 
in both developed and developing countries at both time 
points ( table 1 ).
 By GBD Regions. In 2013, the lowest prevalence for IS 
was seen in Central Latin America, followed by Asian re-
gions, Oceania and Andean Latin America (see online 
suppl. Appendix table  2; for all online suppl. material, 
see www.karger.com/doi/10.1159/000441087), while the 
highest prevalence rates for IS were seen in high-income 
regions of North America. The lowest prevalence of HS 
was seen in North Africa and Middle East, while the high-
est prevalence rates were seen in high-income regions of 
North America.
 By Country . In 2013, the lowest prevalence rates were 
seen in Columbia, Costa Rica, El Salvador, Guatemala 
Honduras, Mexico, Nicaragua, Panama, Venezuela and 
Libya, particularly in children aged 1–4 years (online sup-
pl. appendix table 1a and b). The highest prevalence rates 
were seen in the United States, particularly in those aged 
15–19 years.
 Trends in Prevalence between 1990 and 2013. There 
was a significant increase in the absolute number of prev-
Table 1.  Prevalent cases, deaths and DALYs for IS and HS globally and in developing and developed countries between 1990 and 2013
Absolute numbers Year Prevalence 95% UI Death 95% UI DALY 95% UI
Hemorrhagic
Developed 1990 15,128 13,439–16,937 1,902 1,682–2,301 148,678 131,677–179,622
2013 22,449 19,630–25,868 630 495–750 51,904 41,028–61,750
Developing 1990 67,621 62,899–72,214 60,566 52,183–73,319 4,871,253 4,188,681–5,913,246
2013 73,398 67,869–79,030 28,395 24,676–33,494 2,234,054 1,937,279–2,647,202
Global 1990 82,750 77,758–87,941 62,469 53,898–75,648 5,019,932 4,323,052–6,094,359
2013 95,847 89,651–102,512 29,026 25,251–34,200 2,285,958 1,986,358–2,706,126
Ischaemic
Developed 1990 27,010 24,680–29,417 321 268–420 29,512 25,350–37,518
2013 40,473 36,402–44,973 94 70–124 13,916 10,622–17,343
Developing 1990 44,739 39,918–49,477 8,374 4,611–13,511 675,459 369,500–1,092,588
2013 57,319 51,461–63,926 3,948 3,088–5,114 315,242 248,201–406,367
Global 1990 71,750 66,431–77,031 8,695 4,938–13,862 704,971 397,373–1,124,943
2013 97,792 90,564–106,016 4,043 3,169–5,219 329,159 262,034–420,881
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Table 2.  Prevalence, DALY and death rates (per 100,000) for IS and HS in 4 age groups in developing and developed countries in 1990 
and 2013
Year Sex Age 
group, 
years
IS  HS
developing developed develo ping developed
mean 95% UI mean 95% UI mean 95% UI mean 95% UI
Prevalence 1990 Male 1–4 0.6 0.4–0.7 2 1.7–2.2 0.9 0.8–1.1 1.1 0.9–1.4
Male 5–9 1.7 1.4–2.1 5.7 5.1–6.4 2.8 2.5–3.2 3.2 2.7–4.0
Male 10–14 3.6 3.1–4.2 11.1 9.9–12.3 5.5 5.0–6.2 6.3 5.4–7.3
Male 15–19 5.7 4.9–6.6 17.5 15.5–19.7 8.9 8.0–9.8 10.2 8.8–11.7
Female 1–4 0.4 0.3–0.5 1.3 1.1–1.5 0.6 0.5–0.7 0.7 0.6–0.9
Female 5–9 1.2 1.0–1.5 4 3.5–4.5 1.8 1.6–2.1 2.2 1.9–2.6
Female 10–14 2.6 2.3–3.1 8.2 7.2–9.2 3.7 3.3–4.1 4.4 3.8–5.3
Female 15–19 4.3 3.7–4.9 13.6 11.8–15.5 6.1 5.5–6.7 7.2 6.2–8.9
Both 1–4 0.5 0.4–0.5 1.6 1.5–1.8 0.8 0.7–0.8 0.9 0.8–1.1
Both 5–9 1.5 1.3–1.7 4.9 4.5–5.4 2.3 2.2–2.6 2.7 2.3–3.2
Both 10–14 3.1 2.8–3.5 9.7 8.8–10.5 4.6 4.3–5.0 5.4 4.7–6.0
Both 15–19 5 4.5–5.6 15.6 14.1–17.1 7.5 7.0–8.0 8.8 7.7–9.9
2013 Male 1–4 0.6 0.5–0.7 2.6 2.2–3.1 0.9 0.8–1.0 1.6 1.3–2.0
Male 5–9 1.9 1.6–2.2 8.8 7.4–10.2 2.6 2.4–2.9 5.1 3.9–6.3
Male 10–14 3.9 3.4–4.7 18.8 16.0–21.7 5.2 4.7–5.8 10.7 8.6–13.1
Male 15–19 6.4 5.4–7.6 31.7 26.5–36.9 8.2 7.3–9.2 17.8 14.4–21.9
Female 1–4 0.4 0.4–0.5 1.8 1.5–2.2 0.5 0.5–0.6 1.1 0.8–1.4
Female 5–9 1.3 1.1–1.5 6.6 5.3–7.9 1.6 1.5–1.8 3.9 3.0–5.0
Female 10–14 2.8 2.4–3.2 15.2 12.6–17.9 3.4 3.0–3.8 8.4 6.7–10.3
Female 15–19 4.6 4.0–5.2 26.7 21.9–31.5 5.6 4.9–6.4 13.9 10.7–17.7
Both 1–4 0.5 0.4–0.6 2.3 2.0–2.6 0.7 0.6–0.8 1.4 1.1–1.6
Both 5–9 1.6 1.4–1.8 7.7 6.8–8.7 2.2 2.0–2.3 4.5 3.8–5.3
Both 10–14 3.4 3.0–3.8 17.1 15.4–19.0 4.3 4.0–4.7 9.6 8.3–11.1
Both 15–19 5.5 4.9–6.2 29.3 26.0–32.9 6.9 6.3–7.5 15.9 13.5–18.7
DALY 1990 Male 1–4 44.8 17.7–103.1 8.4 5.8–12.1 263.2 189.1–360.1 28 21.0–37.1
Male 5–9 21.4 10.2–42.8 4.6 3.5–6.7 152.6 119.3–191.6 24.2 19.4–31.3
Male 10–14 18 11.0–29.4 5.5 4.3–7.7 135.7 109.1–169.6 33.8 27.7–41.8
Male 15–19 29.9 18.2–43.4 11.8 9.0–16.9 206.6 165.1–255.3 57.9 44.9–77.3
Female 1–4 50 15.3–112.9 7.1 5.4–10.9 236.3 149.4–370.8 27.1 21.0–38.2
Female 5–9 25.5 9.0–62.5 4.8 3.6–6.8 150.8 107.1–213.1 27.1 20.8–36.5
Female 10–14 17.6 8.43–6.3 5.2 4.0–7.4 121.3 88.9–158.6 33.1 25.7–42.9
Female 15–19 24.2 14.1–44.6 10 7.5–13.9 146.5 99.4–192.1 48.6 35.5–64.4
Both 1–4 47.4 18.7–86.2 7.8 6.1–10.7 250.1 196.2–330.1 27.6 22.8–35.5
Both 5–9 23.4 10.5–42.6 4.7 3.9–6.2 151.7 124.4–190.9 25.6 21.8–31.7
Both 10–14 17.8 11.1–28.2 5.4 4.4–7.3 128.7 108.4–153.7 33.5 29.0–40.1
Both 15–19 27.1 19.4–37.7 10.9 9.0–14.1 177.2 145.7–209.2 53.3 45.2–66.3
2013 Male 1–4 16.4 9.6–29.1 2.9 1.8–4.5 91.9 67.8–122.6 11.2 7.1–16.2
Male 5–9 7.2 4.8–10.7 2.4 1.7–3.2 52 40.5–67.7 8 5.7–10.6
Male 10–14 9.7 6.4–14.0 4.2 2.9–5.8 72.4 56.8–93.9 14.1 10.2–17.8
Male 15–19 22.8 14.7–32.7 8.6 6.0–11.9 139 108.8–177.9 28.2 21.1–36.4
Female 1–4 14.8 9.1–28.0 2.7 1.7–4.1 74.3 52.8–117.0 10.4 6.6–13.8
Female 5–9 8.3 5.2–13.9 2.3 1.6–2.9 51.3 37.9–78.1 8.4 6.1–11.0
Female 10–14 7.7 5.0–13.4 3.8 2.7–5.3 55.6 41.2–80.8 13 9.2–16.2
Female 15–19 14.8 9.4–22.3 7.6 5.4–10.2 82.8 57.8–112.8 22.6 15.3–28.0
Both 1–4 15.6 10.6–24.2 2.8 1.9–4.0 83.4 65.8–110.4 10.8 7.4–14.3
Both 5–9 7.7 5.7–10.8 2.3 1.8–3.0 51.6 41.8–66.8 8.2 6.5–10.1
Both 10–14 8.7 6.5–11.9 4 2.9–5.3 64.3 52.6–80.6 13.5 10.7–16.1
Both 15–19 18.9 14.0–25.0 8.1 6.0–10.6 111.9 92.7–136.3 25.5 20–30.5
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alent cases in both developed and developing countries 
( table 1 ). Globally, and in developing countries, there was 
no significant change in the prevalence rates of either HS 
or IS between 1990 and 2013. However, in developed 
countries, there was a significant 2-fold increase in prev-
alence rates of both IS and HS.
 Deaths 
 GBD 2013 . Globally, in 2013, there were 4,043 (95% UI 
3,169–5,219) deaths from IS and 29,026 (95% UI 25,251–
34,200) deaths from HS in the age group of 0–19 years 
( table 1 ). Men had a trend toward a higher death rate (1.5 
(1.3–1.8) per 100,000) than women (1.1 (0.9–1.5) per 
100,000) globally in 2013. The highest death rates among 
the 4 age groups were in those of 15–19 years, with the 
death rate of men in this age group 1.6-fold higher than 
it was for women. The death rate of IS was 0.2 (95% UI 
0.1–0.2) per 100,000 while the death rate from HS was 1.2 
(95% UI 1.0–1.4) per 100,000 ( table 1 ). The age standard-
ized death rate in children under the age of 1 year in 2013 
was 6.1 (95% UI 5.0–7.5) per 100,000, with the highest 
death rate seen in neonates aged 0–6 days at 79 (95% UI 
61.6–99.2), while the DALY rate for those aged 7–27 days 
was 13 (95% UI 10.4–15.7) and for those aged 28–364 
days, it was 4 (95% UI 3.2–5.3) per 100,000 ( table 3 ).
 Developing vs. Developed Countries. The absolute num-
ber of deaths across age groups in developing countries 
was approximately 30- to 60-fold higher for both IS and 
HS than those in developed countries. However, while 65–
75% decreases in death rates was seen in developed coun-
tries across all age groups, smaller decreases of 42 and 23% 
were seen particularly in the 10–14 and 15–19 year age 
groups, respectively, in developing countries ( fig.  1 ). In 
2013, death rates in developing countries were significant-
ly higher than in developed countries. In 1990, in develop-
ing countries, death rates for IS and HS were highest in the 
age group of 1–4 years; while in 2013, the highest death 
rates for IS and HS were seen in males of 15–19 years. In 
developed countries, in both 1990 and 2013, death rates 
for IS and HS were highest in males of age 15–19 years.
Year Sex Age 
group, 
years
IS  HS
developing developed develo ping developed
mean 95% UI mean 95% UI mean 95% UI mean 95% UI
Deaths 1990 Male 1–4 0.5 0.2–1.2 0.1 0.1–0.1 3.1 2.2–4.3 0.3 0.2–0.4
Male 5–9 0.3 0.1–0.5 0 0–0.1 1.9 1.5–2.4 0.3 0.2–0.4
Male 10–14 0.2 0.1–0.4 0 0–0.1 1.8 1.5–2.3 0.4 0.4–0.6
Male 15–19 0.4 0.3–0.6 0.1 0.1–0.2 3 2.4–3.7 0.8 0.6–1.1
Female 1–4 0.6 0.2–1.3 0.1 0.1–0.1 2.8 1.8–4.4 0.3 0.2–0.5
Female 5–9 0.3 0.1–0.8 0.1 0–0.1 1.9 1.3–2.7 0.3 0.3–0.5
Female 10–14 0.2 0.1–0.5 0.1 0–0.1 1.6 1.2–2.1 0.4 0.3–0.6
Female 15–19 0.3 0.2–0.6 0.1 0.1–0.2 2.1 1.4–2.8 0.7 0.5–0.9
Both 1–4 0.6 0.2–1.0 0.1 0.1–0.1 3 2.3–3.9 0.3 0.3–0.4
Both 5–9 0.3 0.1–0.5 0 0–0.1 1.9 1.6–2.4 0.3 0.3–0.4
Both 10–14 0.2 0.1–0.4 0.1 0–0.1 1.7 1.4–2.1 0.4 0.4–0.5
Both 15–19 0.4 0.3–0.5 0.1 0.1–0.2 2.5 2.1–3.0 0.7 0.6–0.9
2013 Male 1–4 0.2 0.1–0.3 0 0–0 1.1 0.8–1.4 0.1 0.1–0.2
Male 5–9 0.1 0.1–0.1 0 0–0 0.6 0.5–0.8 0.1 0.1–0.1
Male 10–14 0.1 0.1–0.2 0 0–0 1 0.8–1.3 0.2 0.1–0.2
Male 15–19 0.3 0.2–0.5 0.1 0–0.1 2 1.6–2.6 0.4 0.3–0.5
Female 1–4 0.2 0.1–0.3 0 0–0 0.9 0.6–1.4 0.1 0.1–0.2
Female 5–9 0.1 0.1–0.2 0 0–0 0.6 0.5–1.0 0.1 0.1–0.1
Female 10–14 0.1 0.1–0.2 0 0–0 0.7 0.5–1.1 0.2 0.1–0.2
Female 15–19 0.2 0.1–0.3 0 0–0.1 1.2 0.8–1.6 0.3 0.2–0.4
Both 1–4 0.2 0.1–0.3 0 0–0 1 0.8–1.3 0.1 0.1–0.2
Both 5–9 0.1 0.1–0.1 0 0–0 0.6 0.5–0.8 0.1 0.1–0.1
Both 10–14 0.1 0.1–0.2 0 0–0 0.9 0.7–1.1 0.2 0.1–0.2
Both 15–19 0.3 0.2–0.3 0 0–0.1 1.6 1.3–2.0 0.3 0.2–0.4
Table 2. (continued)
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Table 3.  Global DALYs and deaths in neonates in 2013
Age, 
days
Rate 
per 
100,000
95% UI Global 
percent 
change, 
1990–2013
95% UI Developing 
percent 
change, 
1990–2013
95% UI Developed 
percent 
change, 
1990–2013
95% UI
Deaths 0–6 79.3 61.6–99.2 –42.4 –53.8 to –26.9 –41.7 –53.4 to –25.5 –42.4 –53.8 to –26.8
7–27 12.8 10.4–15.7 –57.6 –65.0 to –45.7 –57.3 –64.9 to –45.1 –57.5 –65.0 to –45.6
28–364 4.1 3.2–5.3 –67.5 –73.8 to –59.3 –67.6 –73.8 to –59.3 –67.5 –73.7 to –59.2
Mortality ra te per 100,000 for age 0–364 days: 6.1 (95% UI 5.0–7.5)
DALYs 0–6 6,856.3 5,323.0–8,571.2 –42.4 –53.8 to –26.8 –41.7 –53.4 to –25.5 –80.7 –86.3 to –74.6
7–27 1,105.9 898.0–1,359.0 –57.5 –65.0 to –45.6 –57.3 –64.9 to –45.2 –72.3 –77.7 to –64.8
28–364 357.8 277.8–460.9 –67.5 –73.7 to –59.2 –67.6 –73.8 to –59.3 –64.8 –77.8 to –49.3
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 By GBD Region . According to the GBD, in 2013, death 
rates for IS were lowest in high-income regions of North 
America, Central Latin America, Central Europe and 
Australasia while the highest death rates were found in 
the Caribbean and Central Sub-Saharan Africa. The low-
est death rates for HS were in Southeast Asia, Andean 
Latin America, Eastern Europe and Southern Latin 
 America, while men in the high-income regions of North 
America, Central Asia and Tropical Latin America had 
the highest death rates among the GBD regions.
 The lowest death rates by country for IS were seen in 
Taiwan, Indonesia, Malaysia, Myanmar and Vietnam 
across the age groups, while the highest death rates were 
seen in Sudan in age groups of 10–14 and 15–19 years, 
followed by males of 15–19 years in Sao Tome and 
 Principe and Kiribati (online suppl. appendix table 2).
 Trends in Deaths 1990–2013 . There was a significant 
2-fold decline in absolute numbers of deaths in childhood 
stroke globally between 1990 (71,164 (95% UI 61,122–
84,794)) and 2013 (33,069 (95% UI 28,627–38,998)). 
Globally, there was a significant decline in death rates 
from all stroke types between 1990 (3.2 (95% UI 2.7–3.8)) 
and 2013 (1.3 (95% UI 1.2–2.6)) per 100,000. There was a 
trend toward a decline in the death rate of IS and a sig-
nificant 2.3-fold decline in the death rate of HS between 
1990 and 2013 ( fig. 2 ). There was a significant decline in 
death rates between 1990 and 2013 in both developed and 
developing countries and in both men and women. The 
percentage change between 1990 and 2013 in the absolute 
numbers of HS deaths in developed countries was sig-
nificantly higher than in developing countries, with a 
similar but non-significant trend for IS.
 DALYs 
 In 2013, in absolute numbers, there were 2,615,118 
(95% UI 2,265,801–3,090,822) childhood stroke DALYs 
globally, with 329,159 (95% UI 262,034–420,881) from IS 
and 2,285,958 (95% UI 1,986,358–2,706,126) from HS 
( table 1 ). In neonates, the DALY rates were 6,860 (95% UI 
5,325.8–8,575.7) for age 0–6 days, 1,107 (95% UI 898.5–
1,359.8) for age 7–27 days and 358 (95% UI 277.9–461.2) 
for age 28–364 days ( table 3 ). The DALY rate for child-
hood stroke was 253.5 (95% UI 217.1–303.2) per 100,000. 
The DALYs rates were 13.3 (95% UI 10.6–17.1) for IS and 
92.7 (95% UI 80.5–109.7) for HS per 100,000. Men showed 
a trend toward higher DALY (120.1 (95% UI 100.8–143.4) 
per 100,000) rates than women (90.9 (95% UI 74.6–122.4) 
per 100,000) globally in 2013 ( table 2 ).
 Developing vs. Developed Countries.  The absolute 
number of childhood stroke DALYs in 2013 were signifi-
cantly higher in developing countries (2,549,296 (95% 
UI2,206,063–3,025,321)) compared to developed coun-
tries (65,821 (95% UI 53,205–77,295)). In 2013, DALY 
rates were also significantly higher in developing coun-
tries compared to developed countries ( fig. 1;  table 1 ) and 
also higher in men compared to women.
 By GBD Region . The lowest DALY rates for IS were in 
Andean Latin America, East Asia Central Asia, Central 
Sub-Saharan Africa in females of 1–4 years, while the 
highest were in males of 10–19 years in Eastern Europe, 
East Asia and high-income regions of Asia Pacific. Over-
all, DALYs for HS were approximately 3-fold higher than 
those for IS. The lowest DALY rates were seen in Eastern 
Europe, North Africa and Middle East, Southern Sub- 
Saharan Africa and Tropical Latin America in females of 
1–4 years. The highest DALY rates by GBD region were 
found in males in Southeast Asia, Eastern Sub-Saharan 
Africa, Eastern Europe and Southern Latin America.
 By Country. In terms of DALY rates by country, the 
lowest DALY rates for IS were seen in those of 1–4 years 
in Iceland, followed by Lithuania and Finland (online 
suppl. appendix table 2). The highest DALYs were seen in 
Sudan in those aged 15–19 years, with high rates also seen 
in males of age groups of 1–4 and 5–9 years in Kiribati. 
Similarly, the lowest DALY rates for HS were found in 
Iceland in those of 1–4 years, and the highest DALYs were 
in Zimbabwe in the same age group.
 Trends in DALYs 1990–2013. Between 1990 and 2013, 
the absolute number of childhood stroke DALYs declined 
globally (–54.4% (95% UI –58.8 to –44.7), but there was a 
greater decline in developed countries compared to de-
veloping countries. There was also a significant decline in 
DALY rates between 1990 and 2013 both in developed 
and developing countries. In developed countries, the de-
cline in DALY rates was similar across the age groups, but 
in developing countries, the decline in DALYs rates was 
lower in adolescents (10–19 years;  fig. 1 ). The percentage 
change in absolute numbers of DALYs for HS was sig-
nificantly greater in developed countries, but this differ-
ence was not significant in IS ( fig. 2 ).
 Discussion 
 The GBD 2013 provides the most recent estimates of 
childhood stroke burden, as well as temporal trends in 
stroke burden since 1990. The overall burden of child-
hood stroke increased globally between 1990 and 2013 
with a significant increase in the absolute number of prev-
alent strokes. This reflects increases in the world’s popu-
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lation, increased recognition and diagnosis of childhood 
stroke, increased survival in pediatric conditions that are 
complicated by stroke, and increased survival rates from 
childhood stroke itself. Indeed, the current estimates 
show that the absolute numbers of both deaths and death 
rates have declined significantly. However, death rates 
among infants below the age of 1 year remain high. While 
prevalence rates for IS increased between 1990 and 2013, 
there were significant decreases in death and DALY rates 
globally. This decline in childhood stroke mortality may 
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be a reflection of improving recognition  [30] and post-
stroke medical management of childhood stroke. While 
recent evidence from population-based studies suggests a 
temporal increase in incidence rates  [31, 32] , the differing 
methodologies of childhood stroke studies make it diffi-
cult to make firm conclusions or to speculate on its effects 
on mortality rates. However, incidence studies  [2, 12, 13, 
15–22, 24, 33–36] estimate IS incidence (excluding neo-
nates) at 1.8 (SD 1.78) and HS incidence at 1.59 (SD 0.91) 
per 100,000. Declining rates in mortality from 1960s on-
ward have previously been shown  [10] . Interestingly, a 
birth cohort effect, that is, declining mortality rates with 
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each successive birth cohort from 1950s onward was 
found, suggesting the possibility that factors around time 
of birth may be responsible for declining mortality rates.
 In developing countries, the GBD 2013 data show that 
the overall burden of childhood stroke in 2013 was great-
er than in 1990, with higher prevalence, death rates and 
DALY rates of both IS and HS in such countries. The bur-
den of stroke was highest in low-income countries and 
low-income GBD regions. While prevalence rates of both 
IS and HS in childhood stroke remained stable since 1990, 
these rates were higher in developing countries in com-
parison to developed countries in 2013. However, there 
were disparities in the rate of decline in deaths and DALYs 
in the adolescent/teen age group in developing countries. 
The reason for a slower decline in mortality and DALY 
rates in this group is unclear but could be attributed par-
tially to racial and ethnic differences in stroke outcome. 
The lower decline in death rates in developing countries 
compared to developed countries particularly in neonates 
of 0–27 days may reflect higher rates of undiagnosed 
stroke due to limited imaging resources, lower rates of 
presentation to hospital and poorer healthcare facilities 
in developing countries.
 In 2013, the burden of HS was greater than IS; while 
the prevalence of IS and HS was similar, the death rate 
and DALY rate of HS was 6- to 7-fold higher than that of 
IS. The greatest number of deaths was contributed by HS, 
and overall burden in childhood stroke was greater in HS 
than IS. There is a lack of population-based estimates of 
stroke incidence and mortality in developing countries 
although some data are available  [37–39] , and very few 
that have studied temporal trends; a hospital-based study 
of childhood stroke showed similar proportions of HS to 
IS and a greater burden in men  [40] . These findings re-
flect existing evidence on the greater burden of HS in chil-
dren. Unlike in adults where IS represents approximately 
80% of strokes, HS strokes can account for about 50% of 
the childhood strokes  [22, 32]. A study of temporal trends 
in long-term incidence and case fatality found that case 
fatality rates within 30 days, 1 and 5 years were 2-fold 
higher for HS than for IS  [32] , while a population-based 
study in Denmark found that the odds of dying after HS 
were 1.5-fold higher than after IS  [41] .
 The burden of stroke was greater in men than in wom-
en, particularly in those of 15–19 years, with a trend to-
ward a higher number of absolute numbers of death and 
DALYs and a significantly higher death rate in men. Sim-
ilar findings of higher mortality in men has also been re-
ported elsewhere  [10] , although the reasons for this are 
unclear.
 Higher death rates in developing countries are likely to 
be a reflection of poorer access to healthcare and lower 
rates of hospitalization for stroke, as well as limited avail-
ability of advanced treatment such as thrombolysis and 
surgical interventions. Despite this, the gap in childhood 
stroke burden between developed and developing coun-
tries is closing, an encouraging sign that indicates at im-
provements in healthcare. However, in 2013, childhood 
stroke burden in terms of absolute numbers of prevalent 
strokes, deaths and DALYs remained much higher in de-
veloping countries.
 The current analysis represents the first focused pedi-
atric stroke report from the GBD system. Age-specific es-
timates of both incidence and death, especially for neo-
nates, may reflect inadequate reporting of cases. There are 
notable limitations to the data related to the availability 
and selection of published and unpublished sources. Only 
2 of the 39 data sources selected for this analysis were fo-
cused studies of pediatric stroke  [31, 42] , and many pedi-
atric studies did not meet the GBD inclusion criteria. The 
criteria used to select studies for GBD are the same at all 
ages, which poses particular challenges for estimating 
childhood stroke burden. For example, while many adults 
with stroke remain outpatients after diagnosis, most chil-
dren with stroke are admitted to hospital for manage-
ment. Several published manuscripts specific to child-
hood stroke were not included in GBD 2013  [2, 12, 13, 
15–22, 24, 33–36] and may provide additional inputs for 
modeling as GBD data and methods focused on child-
hood stroke improve.
 Furthermore, the diagnosis of childhood stroke based 
on clinical criteria alone can be particularly challenging 
compared with adults. Children presenting with abrupt 
onset focal deficits harbor non-stroke conditions in 21–
90%  [43] including migraine (28%), seizures (15%), Bell 
palsy (10%), stroke (7%) and conversion disorders (6%) 
 [44] . Therefore, imaging confirmation is required in pe-
diatric stroke diagnosis unlike in adult stroke where the 
clinical diagnosis (not pathological diagnosis of stroke 
types) is based on the WHO criteria. Identification of 
pediatric stroke by the ICD code is more unreliable com-
pared with adult stroke as reported in several studies. For 
example, Golomb et al.  [45] reported that ‘Code accu-
racy ranged from 37 to 88%; each code missed more 
than half of arterial IS identified by the combined code 
search’. Agrawal et al.  [12] found that ICD-9 code search-
es are both insensitive for pediatric stroke and carry a 
poor positive predictive value, and so tends to not 
only miss false-negative cases but also include false-pos-
itives. Much pediatric stroke research has depended on 
 Stroke Prevalence, Mortality and DALYs 
in Children and Youth Aged 0–19 Years 
Neuroepidemiology 2015;45:177–189
DOI: 10.1159/000441087
187
 retrospective observational studies and administrative 
data sets, which have the capacity for the identification 
of a large number of subjects with this relatively rare dis-
ease. However, studies relying on ICD-9 codes alone for 
case identification are not accurate. Cases can be con-
firmed through chart review, although it is not usually 
an option for studies using administrative data sets. Ra-
diology text string searches, although time consuming 
with a low yield, add significantly to the yield of screen-
ing for pediatric stroke cases  [12] . In the face of these 
challenges specific to estimating childhood stroke, fu-
ture GBD analyses may need to consider adapting the 
case definitions for pediatric stroke and obtaining addi-
tional unpublished study results. As childhood stroke 
causes vary across regions, there is also a pressing need 
to collect region-specific data on specific causes of child-
hood stroke.
 In summary, globally, prevalent cases of childhood 
stroke have increased significantly between 1990 and 
2013; however, childhood stroke death and DALY rates 
have declined significantly. In 2013, the overall burden of 
stroke was significantly higher in developing countries 
compared to developed countries and greater in men 
than in women. Childhood stroke burden was greater due 
to HS than IS.
 Data on childhood stroke remain limited, particularly 
in developing countries and for neonatal stroke. Addi-
tional investment will be needed for surveillance and ep-
idemiologic research in order to better inform policy 
makers facing decisions on how to invest in healthcare for 
children. In particular, regional disparities in childhood 
stroke burden will require both global and local initiatives 
targeted at improving access to acute and chronic stroke 
care for children.
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 Appendix 
 GBD Stroke Expert Panel Members (in Alphabetical Order by 
Country) 
 Argentina (Maria Cecilia Bahit);  Australia (Amanda G. 
Thrift, Atte Meretoja, Bill Stavreski, Craig S. Anderson, Edwin 
Pearse, Geoffrey Donnan, Graeme J. Hankey, Mark T. Mackay, 
Stephen Davis, Zanfina Ademi); Austria (Michael Brainin); 
 Azerbaijan (Tural  Guliyev);  Bahrain (Randah R. Hamadeh); 
 Barbados (Heather  Harewood, Karen Springer);  Brazil (Iuri da 
Costa Leite, Jefferson Gomes Fernandes, Norberto Luiz Cabral, 
Paulo A. Lotufo);  Bulgaria (Klara Dokova);  Canada (Farshad 
Pourmalek, Gabrielle deVeber, Luciano A. Sposato, M. Patrice 
Lindsay, Patricia M. Riccio);  Chile (Pablo M. Lavados);  China (Bin 
Li, Chuanhua Yu, Guohong Jiang, Jixiang Ma, Maigeng Zhou, 
Ming Liu, Shankuan Zhu, Wenzhi Wang, Xiaofeng Liang, Yong 
Zhang);  Colombia (Gabriel  Alcalá-Cerra),  Denmark (Hanne K. 
Christensen, Thomas Truelsen);  Egypt (Foad Abd-Allah); 
 Ethiopia (Awoke Temesgen, Berhe Weldearegawi Sahle, Semaw 
Ferede Abera, Yohannes Adama Melaku),  Fiji (Devina Nand); 
 France (Maurice Giroud);  Germany (Jost B. Jonas, Matthias En-
dres, Ronny Westerman);  Greece (Konstantinos Stroumpoulis); 
 India (Dorairaj Prabhakaran, Jeyaraj Durai Pandian, Man Mohan 
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